(2S,4R)-1-[(Benzyloxy)carbonyl]-4-methoxypyrrolidine-2-carboxylic acid

Catalog No. :
ACBTRM840
CAS No. :
96522-37-1
Molecular Formula :
C14H17NO5
Molecular Weight :
279.29

IUPAC Name:(2S,4R)-1-((benzyloxy)carbonyl)-4-methoxypyrrolidine-2-carboxylic acid

(2S,4R)-1-[(Benzyloxy)carbonyl]-4-methoxypyrrolidine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$289.00Login to see priceInquiryInquiry
100mg98%$426.00Login to see priceInquiryInquiry
250mg98%$602.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,4R)-1-[(Benzyloxy)carbonyl]-4-methoxypyrrolidine-2-carboxylic acid
IUPAC Name(2S,4R)-1-((benzyloxy)carbonyl)-4-methoxypyrrolidine-2-carboxylic acid
MDL No.MFCD30345339
Molecular FormulaC14H17NO5
Molecular Weight279.29
SMILESO=C([C@H]1N(C(OCC2=CC=CC=C2)=O)C[C@H](OC)C1)O
InChI KeySRQAKAAEVLROCY-NEPJUHHUSA-N
Synonym(2S,4R)-1-((benzyloxy)carbonyl)-4-methoxypyrrolidine-2-carboxylic acid;1,2-Pyrrolidinedicarboxylic acid, 4-methoxy-, 1-(phenylmethyl) ester, (2S,4R)-
CAS No.96522-37-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBTRM840 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUXYW749 route compound structure diagram
    ACUXYW74913504-85-3 In Stock
  4. Then
  5. ACBTRM840 route product structure diagram
    ACBTRM84096522-37-1
Inquiry

2. ACBTRM840 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBTRM840 route product structure diagram
    ACBTRM84096522-37-1
Inquiry

Comments (0)